HLA-E and neoplasm: HLA-E overexpression was not correlated with any clinical prognostic factors such as FIGO (Chi2 test, p = 0.36), performance status (Chi2 test, p = 0.92), age (Wilcoxon test, p = 0.68), and residual tumor (Chi2 test, p = 0.75).